Omthera announces positive bioavailability data from Epanova study
Epanova increased EPA and DHA more than 5-Fold Compared to Lovaza After two weeks of dosing in 52 subjects on a low fat diet. Additionally, Epanova increased steady
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
Relovair is a once-daily inhaled corticosteroid (ICS)/long-acting beta-agonist (LABA) combination treatment, comprising fluticasone furoate and vilanterol (FF/VI), currently in development for the treatment of COPD and asthma. The
BioReliance provides services including biologic, specialized toxicology and animal health testing to pharmaceutical, biopharmaceutical, diagnostics. BioReliance’s service is believed to help facilitate biological drug development, manufacturing and commercialization